Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Nicol, MBChB, PhD
University of Cape Town, Faculty of Health Sciences, Dept. of Medical Microbiology, Cape Town, South Africa
Principal Investigator - Mischka Moodley, MBChB, DTM&H, FCPath(Micro)SA
University of Cape Town, Faculty of Health Sciences, Dept. of Medical Microbiology, Cape Town, South Africa
Principal Investigator - Susan Dorman, MD
Johns Hopkins University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- G.F. Jooste Hospital
Cape Town, Western Cape, South Africa
- Town Two Clinic
Cape Town, Western Cape, South Africa
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2011
- Primary completion
- 28 Feb 2013
- Completion
- 28 Feb 2013
- Last update posted
- 26 Sept 2012
- Registered enrollment
- 512
- Registry id
- NCT01693224
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.